4.8 Article

Lipid-Modified Aminoglycoside Derivatives for In Vivo siRNA Delivery

Journal

ADVANCED MATERIALS
Volume 25, Issue 33, Pages 4641-4645

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.201301917

Keywords

siRNA; drug delivery; nanoparticle; gene knockdown; aminoglycoside

Funding

  1. Alnylam Pharmaceuticals, Inc.
  2. NIH [EB000244, 1-RO1-CA132091-03]
  3. Damon Runyon Cancer Research Foundation (DFS) [2050-10]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available